申请人:THOMAS JEFFERSON UNIVERSITY
公开号:US20150209379A1
公开(公告)日:2015-07-30
Prostate cancer and hematological neoplasms are treated by administration of (i) a compound of Formula I: wherein: R
1
is —OH or —O—P(O)(OH)
2
; and R
2
is (II) or (III); (ii) N
6
-benzyladenosine, (iii) N-(phenylmethyl)-7-β-D-ribofuranosyl-7H-pyrrolo [2,3 -d]pyrimidin-4-amine, (iv) N-(phenylmethyl)-7β-D-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine 5′-monophosphate; or a pharmaceutically acceptable salt thereof.
前列腺癌和血液肿瘤可通过给予以下药物治疗:(i) 公式I中的化合物:其中:R1为—OH或—O—P(O)(OH)2; R2为(II)或(III); (ii) N6-苄基腺嘌呤,(iii) N-(苯甲基)-7-β-D-核糖呋喃基-7H-吡咯[2,3-d]嘧啶-4-胺,(iv) N-(苯甲基)-7β-D-核糖呋喃基-7H-吡咯[2,3-d]嘧啶-4-胺5′-磷酸酯;或其药学上可接受的盐。